Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication
William James Deardorff, Ahmad Shobassy, George T. Grossberg
Expert Review of Neurotherapeutics (2014) Vol. 15, Iss. 1, pp. 7-17
Closed Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

REVISITING THE CHOLINERGIC HYPOTHESIS IN ALZHEIMER’S DISEASE: EMERGING EVIDENCE FROM TRANSLATIONAL AND CLINICAL RESEARCH
Harald Hampel, M.‐Marsel Mesulam, A. Claudio Cuello, et al.
The Journal of Prevention of Alzheimer s Disease (2018), pp. 1-14
Closed Access | Times Cited: 267
Advances in developing novel therapeutic strategies for Alzheimer’s disease
Jiqing Cao, Jianwei Hou, Jing Ping, et al.
Molecular Neurodegeneration (2018) Vol. 13, Iss. 1
Open Access | Times Cited: 237
Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease
Teeba Athar, Khalid Al Balushi, Shah Alam Khan
Molecular Biology Reports (2021) Vol. 48, Iss. 7, pp. 5629-5645
Open Access | Times Cited: 185
Structural mechanisms of α7 nicotinic receptor allosteric modulation and activation
Sean M. Burke, Mariia Avstrikova, Colleen Noviello, et al.
Cell (2024) Vol. 187, Iss. 5, pp. 1160-1176.e21
Open Access | Times Cited: 17
Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease
Kaige Ma, Yi‐Hua Qian
Neuropeptides (2018) Vol. 73, pp. 96-106
Closed Access | Times Cited: 118
The current agonists and positive allosteric modulators of α 7 nAChR for CNS indications in clinical trials
Taoyi Yang, Ting Xiao, Qi Sun, et al.
Acta Pharmaceutica Sinica B (2017) Vol. 7, Iss. 6, pp. 611-622
Open Access | Times Cited: 104
Linking the biological underpinnings of depression: Role of mitochondria interactions with melatonin, inflammation, sirtuins, tryptophan catabolites, DNA repair and oxidative and nitrosative stress, with consequences for classification and cognition
George Anderson
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 80, pp. 255-266
Closed Access | Times Cited: 98
Neuroprotective Effects of Cholinesterase Inhibitors: Current Scenario in Therapies for Alzheimer’s Disease and Future Perspectives
Natália Moreira, Jéssica Ellen Barbosa de Freitas Lima, Marcelo Fiori Marchiori, et al.
Journal of Alzheimer s Disease Reports (2022) Vol. 6, Iss. 1, pp. 177-193
Open Access | Times Cited: 59
Targeting α7 nicotinic acetylcholine receptors and their protein interactions in Alzheimer's disease drug development
Lindsay H. Burns, Zhe Pei, Hoau‐Yan Wang
Drug Development Research (2023) Vol. 84, Iss. 6, pp. 1085-1095
Closed Access | Times Cited: 24
An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia
Hongfeng Zhang, Libo Huang, Yan-Biao Zhong, et al.
Frontiers in Aging Neuroscience (2016) Vol. 8
Open Access | Times Cited: 72
The Therapeutic Potential of α7 Nicotinic Acetylcholine Receptor (α7 nAChR) Agonists for the Treatment of the Cognitive Deficits Associated with Schizophrenia
Corinne Beinat, Samuel D. Banister, Marco Herrera-Barrera, et al.
CNS Drugs (2015) Vol. 29, Iss. 7, pp. 529-542
Closed Access | Times Cited: 66
Interactions of Tryptophan and Its Catabolites With Melatonin and the Alpha 7 Nicotinic Receptor in Central Nervous System and Psychiatric Disorders: Role of the Aryl Hydrocarbon Receptor and Direct Mitochondria Regulation
George Anderson, Michaël Maes
International Journal of Tryptophan Research (2017) Vol. 10
Open Access | Times Cited: 66
Novel Anti-Alzheimer’s Therapeutic Molecules Targeting Amyloid Precursor Protein Processing
Md. Sahab Uddin, Md. Tanvir Kabir, Philippe Jeandet, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-19
Open Access | Times Cited: 59
Ca2+ Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer’s Disease
John McDaid, Sarah Mustaly-Kalimi, Grace E. Stutzmann
Cells (2020) Vol. 9, Iss. 12, pp. 2655-2655
Open Access | Times Cited: 54
Se-methylselenocysteine ameliorates mitochondrial function by targeting both mitophagy and autophagy in the mouse model of Alzheimer's disease
Yongli Xie, Xiaoshan Ke, Z. Ye, et al.
Food & Function (2024) Vol. 15, Iss. 8, pp. 4310-4322
Closed Access | Times Cited: 7
Small-molecule drugs development for Alzheimer's disease
Weiwei Yao, Huihui Yang, Jinfei Yang
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 23
Advances of computer-aided drug design (CADD) in the development of anti-Azheimer’s-disease drugs
Yuzhen Niu, Ping Lin
Drug Discovery Today (2023) Vol. 28, Iss. 8, pp. 103665-103665
Closed Access | Times Cited: 16
Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker
Kenji Hashimoto
Current Pharmaceutical Design (2015) Vol. 21, Iss. 26, pp. 3797-3806
Open Access | Times Cited: 49
The multiple roles of the α7 nicotinic acetylcholine receptor in modulating glutamatergic systems in the normal and diseased nervous system
Fani Koukouli, Uwe Maskos
Biochemical Pharmacology (2015) Vol. 97, Iss. 4, pp. 378-387
Closed Access | Times Cited: 48
Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of Success
Haruhiko Sugino, Akihito Watanabe, Naoki Amada, et al.
Clinical Therapeutics (2015) Vol. 37, Iss. 8, pp. 1632-1642
Open Access | Times Cited: 42
Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation
Buranee Kanchanatawan, Sunee Sirivichayakul, Kiat Ruxrungtham, et al.
Molecular Neurobiology (2017) Vol. 55, Iss. 3, pp. 2214-2226
Closed Access | Times Cited: 42
How Immune-inflammatory Processes Link CNS and Psychiatric Disorders: Classification and Treatment Implications
George Anderson, Michaël Maes
CNS & Neurological Disorders - Drug Targets (2017) Vol. 16, Iss. 3, pp. 266-278
Closed Access | Times Cited: 41
Role of the Cholinergic Anti-Inflammatory Reflex in Central Nervous System Diseases
Iván Ramos-Martínez, Maria Carmen Rodríguez, Marco Cerbón, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13427-13427
Open Access | Times Cited: 30
Geroprotective interventions in the 3xTg mouse model of Alzheimer’s disease
Michelle M. Sonsalla, Dudley W. Lamming
GeroScience (2023) Vol. 45, Iss. 3, pp. 1343-1381
Open Access | Times Cited: 11
Structural basis for allosteric agonism of human α7 nicotinic acetylcholine receptors
Sanling Liu, Yining Zheng, Haopeng Chen, et al.
Cell Discovery (2025) Vol. 11, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top